Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...